Yamaguchi University
12 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
2
Ending by 2030
Aug 2028
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Dec 11, 2026The maintenance fee for Car Expression Vector and Car-Expressing T Cells (US 10,316,102) comes due Dec 11, 2026. Unpaid by Jun 11, 2027, it lapses early.
- 2 fees due Jan 4 to 16, 2027 · next Jan 4
- 2 fees due Feb 18 to 22, 2027 · next Feb 18
- 1 fee due Apr 22, 2027The maintenance fee for Buffer composition for hybridization use, and hybridization method (US 10,450,601) comes due Apr 22, 2027. Unpaid by Oct 22, 2027, it lapses early.
- 1 fee due Jul 21, 2027The maintenance fee for Therapeutic Agent for Keratoconjunctive Disorders (US 10,537,556) comes due Jul 21, 2027. Unpaid by Jan 21, 2028, it lapses early.
- 2 fees due Sep 1 to 19, 2027 · next Sep 1
- 1 fee due Oct 14, 2027The maintenance fee for Thickening Stabilizer and Thickening Stabilizer Composition Including Same (US 10,618,919) comes due Oct 14, 2027. Unpaid by Apr 14, 2028, it lapses early.
Recent changes
- 2 of the patents on this record were granted since Aug 19, 2026
- 1 term has ended since Aug 19, 2026
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,334,122 | Thermotolerant ethanol-producing yeast and ethanol production method utilizing the same In force · From the USPTO record | In force | From the USPTO record | |
| US 7,943,311 | Kits and method for determining the risk of adverse effects of irinotecan comprising hybridizing pairs of nucleic acid probes In force · From the USPTO record | In force | From the USPTO record | |
| US 9,433,421 | Surgical tool for anastomosis In force · From the USPTO record | In force | From the USPTO record | |
| US 8,633,029 | Agent for improving gene transfer efficiency to mammalian cells In force · From the USPTO record | In force | From the USPTO record | |
| US 9,107,876 | Surface anesthetic agent In force · From the USPTO record | In force | From the USPTO record | |
| US 9,274,021 | Leakage inspection apparatus and leakage inspection method In force · From the USPTO record | In force | From the USPTO record | |
| US 9,492,431 | Therapeutic Agent for Keratoconjunctive Disorders In force · High confidence | In force | High confidence | |
| US 9,750,721 | Therapeutic Agent for Keratoconjunctive Disorders In force · Medium confidence | In force | Medium confidence | |
| US 10,016,395 | Therapeutic Agent for Keratoconjunctive Disorders In force · Medium confidence | In force | Medium confidence | |
| US 10,537,556 | Therapeutic Agent for Keratoconjunctive Disorders In force · Medium confidence | In force | Medium confidence |
Also on record, not counted in the 41: 12 patents in force now held by others · 34 lapsed for an unpaid fee · 1 ended at full term. List them
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
14 pending · 11 abandoned · 22 no status recorded